BridgeBio Oncology Therapeutics, Inc. BBOT
Full chart
Set alert
2.14 USD -0.21 (-8.94%)
Regular-session close
2.14 0.00 0.00%
After hours · Nov 13, 4:00 PM ET
2.11 Day range 2.37
2.04 52-week range 13.73
- YTD
- -82.91%
- 1 year
- -82.71%
1Y chart
Chart tools· Candles· 4 studies
Signals (47)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 2, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 2 months ago |
| RSI: Oversold | Sep 9, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 21, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 19, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 18, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 5, 2026 | 3 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| SMA: Bearish | Jul 31, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 29, 2026 | 3 months ago |
| SMA: Bullish | Jul 6, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 25, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 24, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 22, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 3, 2026 | 5 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | May 28, 2026 | 5 months ago |
| SMA: Bearish | May 22, 2026 | 5 months ago |
| SMA: Bullish | May 20, 2026 | 5 months ago |
| MACD: Buy Signal | May 14, 2026 | 6 months ago |
Newest 20 of 47.
Compare BBOT
Chart and line up BBOT against other symbols or a saved comparison set.
- BBOT BridgeBio Oncology Therapeutics, Inc.
2.14
-0.21 -8.94%
- SPY State Street SPDR S&P 500 ETF Trust
754.37
-2.75 -0.36%
- QQQ Invesco QQQ Trust
679.89
-8.28 -1.20%
Sign in to keep these symbols in a saved comparison set.
| Metric | BBOT | SPY | QQQ |
|---|---|---|---|
| Last price | 2.14 | 754.37 | 679.89 |
| Change | -0.21 | -2.75 | -8.28 |
| Change % | -8.94% | -0.363219% | -1.20% |
| Open | 2.37 | 760.07 | 688.51 |
| Day high | 2.37 | 760.12 | 688.75 |
| Day low | 2.11 | 747.89 | 671.71 |
| Previous close | 2.35 | 757.12 | 688.17 |
| Volume | 677.60K | 38.72M | 42.10M |
| Average volume | 607.56K | 42.92M | 38.50M |
| Market cap | 171.74M | 802.99B | 472.40B |
| P/E ratio | 4.04 | 24.00 | 28.00 |
| Earnings per share | 0.53 | 31.43 | 24.28 |
| Dividend yield | 0.00 | 0.00 | 0.00 |
| 52-week high | 13.73 | 779.09 | 759.66 |
| 52-week low | 2.04 | 631.97 | 558.28 |
| 1-week return | +4.90% | +2.59% | +3.63% |
| 1-month return | -27.46% | -3.04% | -8.56% |
| 3-month return | -76.81% | -3.02% | -7.13% |
| 6-month return | -73.51% | +1.62% | -4.87% |
| Year-to-date return | -82.91% | +10.62% | +10.68% |
| 1-year return | -82.71% | +12.25% | +11.75% |
| 2-year return | -79.66% | +26.32% | +32.73% |
| 50-day moving average | 3.79 | 764.43 | 717.87 |
| 200-day moving average | 7.69 | 731.92 | 682.24 |
| Target price | 24.20 | — | — |
| Beta | 0.86 | 1.00 | 1.24 |
| Short ratio | 4.43 | — | — |
| Institutional ownership | 52.88% | — | — |